cemiplimab,pembrolizumab,cabozantinib,nivolumab,ipilimumab
merck,bms,sanofi,regeneron
['nivolumab', 'pembro', 'cemiplimab', 'cabozantinib', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'ipilimumab', 'advanced i', 'nivo', 'imab ']
safety and efficacy of immune checkpoint inhibitors (ici) in adv. penile scc -orr 13%
-pfs 3.2 and os 9.8 months
#gu23 #medtwitter 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni